HCVAD plus imatinib or dasatinib in lymphoid blastic phase chronic myeloid leukemia-Reference-Cited by-同舟云学术

HCVAD plus imatinib or dasatinib in lymphoid blastic phase chronic myeloid leukemia

Published:2013-10-22 Issue:3 Volume:120 Page:373-380
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Strati Paolo¹,Kantarjian Hagop¹,Thomas Deborah¹,O'Brien Susan¹,Konoplev Sergej²,Jorgensen Jeffrey L.²,Luthra Raja²,Abruzzo Lynne²,Jabbour Elias¹,Quintas-Cardama Alfonso¹,Borthakur Gautam¹,Faderl Stefan¹,Ravandi Farhad¹,Cortes Jorge¹

Affiliation:

1. Department of Leukemia; The University of Texas MD Anderson Cancer Center; Houston Texas

2. Department of Hematopathology; The University of Texas MD Anderson Cancer Center; Houston Texas

Funder

NIH

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference33 articles.

1. Characteristics of the terminal phase of chronic granulocytic leukemia;Karanas;Blood,1968

2. The blast phase of chronic myeloid leukaemia;Silver;Best Pract Res Clin Haematol,2009

3. Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia;Druker;N Engl J Med,2006

4. Sequential karyotype study on Ph-positive chronic myelocytic leukemia. Significance of additional chromosomal abnormalities during disease evolution;Krulik;Cancer,1987

5. How I treat CML blast crisis;Hehlmann;Blood,2012

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Investigations on druggable gene mutations related to AML/ALL lineage genes in Advanced Phases of CML: Implications in patient-tailored therapy of blast crisis CML in TKI era;2024-09-09

2. Management and outcome of patients with chronic myeloid leukemia in blast phase in the tyrosine kinase inhibitor era – analysis of the European LeukemiaNet Blast Phase Registry;Leukemia;2024-03-28

3. Stem cell allografting for chronic Myeloid leukemia in the tyrosine kinase era – forgotten but not gone;Leukemia & Lymphoma;2024-02-09

4. Chronic Myeloid Leukemia: Advance Phases of the Disease;Cancer Consult;2023-11-18

5. An Update on the Management of Advanced Phase Chronic Myeloid Leukemia;Current Hematologic Malignancy Reports;2023-08-31